Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen.

scientific article

Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1099/00222615-41-5-295
P698PubMed publication ID7966200
P5875ResearchGate publication ID15233440

P2093author name stringSamaranayake LP
Samaranayake YH
P433issue5
P921main subjectepidemiologyQ133805
Candida kruseiQ289229
emerging pathogenQ108429945
P304page(s)295-310
P577publication date1994-11-01
P1433published inJournal of Medical MicrobiologyQ15708716
P1476titleCandida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen.
P478volume41

Reverse relations

cites work (P2860)
Q37802257A Review of the Ultrastructural Features of Superficial Candidiasis
Q39630911A monoclonal antibody specific to surface antigen on Candida krusei.
Q73390114Adhesion of Candida albicans, but not Candida krusei, to salivary statherin and mimicking host molecules
Q77758736Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents
Q44259661Adhesion of oral Candida species to human buccal epithelial cells following brief exposure to nystatin
Q46601907Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model
Q33749111Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance
Q35752870Antifungals in systemic neonatal candidiasis
Q95852835Antimicrobial Activities of New Indole Derivatives Containing 1,2,4-Triazole, 1,3,4-Thiadiazole and Carbothioamide
Q73198861Bilateral endogenous Candida endophthalmitis and chorioretinitis following toxic megacolon
Q34004133Candida albicans and Candida krusei differentially induce human blood mononuclear cell interleukin-12 and gamma interferon production
Q90013376Candida biome of severe early childhood caries (S-ECC) and its cariogenic virulence traits
Q38453829Candida glabrata, an emerging fungal pathogen, exhibits superior relative cell surface hydrophobicity and adhesion to denture acrylic surfaces compared with Candida albicans
Q28260910Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005
Q38028552Candida krusei: biotechnological potentials and concerns about its safety
Q43839118Case report. Successful treatment of two cases of post-surgical sternal osteomyelitis, due to Candida krusei and Candida albicans, respectively, with high doses of triazoles (fluconazole, itraconazole).
Q54312142Close association between oral Candida species and oral mucosal disorders in patients with xerostomia.
Q39502192Comparative evaluation of Fungitest-, Neo-Sensitabs- and M27T-NCCLS broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans
Q40625997Comparison of PCR- and HinfI restriction endonuclease-based methods for typing of Candida krusei isolates.
Q37352730Development of Candida-associated denture stomatitis: new insights
Q58838532Emergence of Saccharomyces cerevisiae as a human pathogen
Q37900678Evaluating the role of prophylaxis in the management of invasive fungal infections in patients with hematologic malignancy.
Q33975696Experimental oral candidiasis in animal models
Q34988444High oral prevalence of Candida krusei in leprosy patients in northern Thailand.
Q41783468Identification and Sequencing of Candida krusei Aconitate Hydratase Gene Using Rapid Amplification of cDNA Ends Method and Phylogenetic Analysis.
Q35056809In Vitro and In Vivo Activities of Essential Oil from the Seed of Anethum graveolens L. against Candida spp.
Q39830466In vitro Impact of Limited Exposure to Subtherapeutic Concentrations of Chlorhexidine Gluconate on the Adhesion-Associated Attributes of Oral Candida Species
Q77931985In vitro activities of antimicrobial agents against Candida species
Q41042117In vitro method to study antifungal perfusion in Candida biofilms
Q64120011Linking Cellular Morphogenesis with Antifungal Treatment and Susceptibility in Pathogens
Q73081254Nucleic acid sequence-based amplification (NASBA) detection of medically important Candida species
Q58271063Oral Candidiasis and the Medically Compromised Patient
Q34632651Oral candidal infections and antimycotics
Q50053143Photodynamic antimicrobial chemotherapy (PACT) using toluidine blue inhibits both growth and biofilm formation by Candida krusei.
Q24550528Prevention of yeast spoilage in feed and food by the yeast mycocin HMK
Q44440005Rapid and cost-effective identification of Candida species using multipoint inoculation of CHROMagar Candida media, cycloheximide sensitivity and carbohydrate assimilation tests
Q73864757Rare non-albicans Candida species detected in different clinical diagnoses
Q59113063Recurring Events of Candida krusei Septicaemia: First Report from an ICU
Q40172874Restriction enzyme analysis of ribosomal DNA shows that Candida inconspicua clinical isolates can be misidentified as Candida norvegensis with traditional diagnostic procedures.
Q43753773Role of hydrophobicity in adhesion of wild yeast isolated from the ultrafiltration membranes of an apple juice processing plant
Q77695984Routine use of CHROMagar Candida medium for presumptive identification of Candida yeast species and detection of mixed fungal populations
Q36544229Species differentiation by internally transcribed spacer PCR and HhaI digestion of fluconazole-resistant Candida krusei, Candida inconspicua, and Candida norvegensis strains.
Q60047553Strong Synergism of Palmatine and Fluconazole/Itraconazole Against Planktonic and Biofilm Cells of Species and Efflux-Associated Antifungal Mechanism
Q59113064The Anticandidal and Toxicity Properties of Lampranthus francisci
Q46238781The Candida species that are important for the development of atrophic glossitis in xerostomia patients
Q36718267The Comparison of vaginal cream of mixing yogurt, honey and clotrimazole on symptoms of vaginal candidiasis
Q30501710The interaction between Candida krusei and murine macrophages results in multiple outcomes, including intracellular survival and escape from killing
Q38261303Uncommon opportunistic fungal infections of oral cavity: A review
Q37393878Understanding the Antifungal Mechanism of Ag@ZnO Core-shell Nanocomposites against Candida krusei
Q41188065Update on invasive candidiasis
Q38684199Whole Genome Sequence of the Heterozygous Clinical Isolate Candida krusei 81-B-5.

Search more.